David García-Azorín, Cristina Martínez-Badillo, Javier Camiña Muñiz, Ana Beatriz Gago-Veiga, Noemi Morollón Sánchez, Vicente González-Quintanilla, Jesús Porta-Etessam, Alvaro Sierra-Mencía, Nuria González-García, Yésica González-Osorio, Marcos Polanco-Fernandez, Andrea Recio-García, Robert Belvis Nieto, Angel Luis Guerrero-Peral
INTRODUCTION: Effectiveness of candesartan in migraine prevention is supported by two randomized controlled trials. We aimed to assess the effectiveness, tolerability, and response predictors of candesartan in the preventive treatment of migraine. METHODS: Observational, multicenter, prospective cohort study. The 50%, 75% and 30% responder rates, between weeks 8-12 and 20-24, were compared with the baseline. Treatment emergent adverse effects were systematically evaluated...
April 2024: Cephalalgia: An International Journal of Headache